MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    A perception of knowledge on Parkinson’s disease among University students

    K. Gohain, M. Changmai (Shah Alam, Malaysia)

    Objective: The objective of this study is to understand the extent of awareness among the respondents on signs, symptoms, and management of Parkinson’s disease. Background:…
  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • MDS Virtual Congress 2021

    How can patients’ trajectories inform the co-design of an integrated care network for people living with Parkinson’s Disease?

    S. Grosjean, J. Farré Coma, O. Gal, A. Laffan, A. Sendra, J. Stuempel, T. Mestre (Ottawa, Canada)

    Objective: The aim of this study is to provide a better understanding of how patients’ experience could inform the design of an integrated care network…
  • MDS Virtual Congress 2021

    Motor evaluation of Parkinson’s disease patients through video consultations in the Brazilian public health system – a real life feasibility study

    D. Dos Santos, D. Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To assess the feasibility and quality of evaluating motor symptoms through video consultations for Parkinson disease’s (PD) patients in the Brazilian public health system.…
  • MDS Virtual Congress 2021

    The OCEAN (OpiCapone Effect on motor fluctuations and associated pAiN) study in Parkinson’s disease: design and rationale of a randomized double-blind placebo-controlled trial

    K. Chaudhuri, P. Odin, J. Ferreira, A. Antonini, O. Rascol, M. Kurtis, A. Storch, K. Bannister, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (London, United Kingdom)

    Objective: To evaluate if treatment with opicapone (OPC) in patients with Parkinson’s disease (PD) improves pain related to end-of-dose fluctuations, consequently improving patients’ well-being. Background:…
  • MDS Virtual Congress 2021

    Dual-task interference on weight-shifting in Parkinson’s Disease with freezing of gait and without freezing of gait

    YT. Hung, CY. Tsai, RM. Wu, CY. Huang (Taipei, Taiwan)

    Objective: To investigate the control of dual-task weight-shifting in Parkinson's disease (PD) with freezing of gait (FOG) and without FOG). Background: With more impairment in…
  • MDS Virtual Congress 2021

    The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To examine the experience profile of PD Diary raters in clinical trials Background: The Parkinson’s Disease (PD) Home Diary (Hauser, 2000)1 is a widely…
  • MDS Virtual Congress 2021

    The effect of Nordic Walking on respiratory function, pain and gait in Parkinson’s disease

    J. Stożek, W. Falewska, S. Podsiadło (Krakow, Poland)

    Objective: To assess the effect of rehabilitation program based on exercises and Nordic Walking (NW) on respiratory function, range of chest mobility, pain and gait…
  • MDS Virtual Congress 2021

    VMAT2 OVEREXPRESSION REDUCES INTRACELLULAR NEUROMELANIN LEVELS AND ATTENUATES PARKINSON-LIKE PATHOLOGY IN NEUROMELANIN-PRODUCING PARKINSONIAN RATS

    J. Compte, M. González, A. Nicolau, T. Cuadros, J. Romero, A. Parent, A. Laguna, M. Vila (Barcelona, Spain)

    Objective: Because neuromelanin derives from the oxidation of free cytosolic dopamine, we hypothesized that enhancing dopamine vesicular encapsulation with vesicular monoamine transporter 2 (VMAT2) will…
  • MDS Virtual Congress 2021

    α-synuclein expression is not mediated by β2-adrenoreceptor modulation in human dopaminergic cells

    M. Langmyhr, IH. Flønes, CC. Cappelletti, C. Tzoulis, M. Toft (Oslo, Norway)

    Objective: Modulation of the β2-adrenoreceptor (also called the β2-adrenergic receptor or β2-adrenoceptor) has been reported to regulate SNCA expression. We sought to determine the expression…
  • « Previous Page
  • 1
  • …
  • 510
  • 511
  • 512
  • 513
  • 514
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley